Surmodics Inc (SRDX)

Nov 6, 2024, 7:00 AM EST - 2 months ago

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Oct 30, 2024, 2:30 PM EDT - 2 months ago

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System

Oct 1, 2024, 7:00 AM EDT - 3 months ago

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

Jul 31, 2024, 7:00 AM EDT - 6 months ago

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Jul 17, 2024, 4:31 PM EDT - 6 months ago

SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

Jun 10, 2024, 7:00 AM EDT - 7 months ago

Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

May 30, 2024, 10:30 PM EDT - 8 months ago

SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

May 29, 2024, 6:36 PM EDT - 8 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.

May 29, 2024, 7:00 AM EDT - 8 months ago

Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

May 1, 2024, 4:07 PM EDT - 9 months ago

Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 9 months ago

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Apr 19, 2024, 7:00 AM EDT - 9 months ago

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

Feb 27, 2024, 8:00 AM EST - 11 months ago

Surmodics to Participate in Upcoming Investor Conferences in March and April

Feb 1, 2024, 2:41 PM EST - 1 year ago

Surmodics, Inc (SRDX) Q1 2024 Earnings Call Transcript

Feb 1, 2024, 7:00 AM EST - 1 year ago

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Jan 22, 2024, 7:30 AM EST - 1 year ago

Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee

Jan 16, 2024, 7:30 AM EST - 1 year ago

Surmodics to Host Virtual Annual Meeting of Shareholders

Jan 16, 2024, 7:30 AM EST - 1 year ago

Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Nov 16, 2023, 7:30 AM EST - 1 year ago

Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

Nov 16, 2023, 7:30 AM EST - 1 year ago

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Nov 14, 2023, 4:05 PM EST - 1 year ago

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

Nov 10, 2023, 10:06 AM EST - 1 year ago

Surmodics, Inc. (SRDX) Q4 2023 Earnings Call Transcript

Nov 8, 2023, 7:30 AM EST - 1 year ago

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

Nov 7, 2023, 7:30 AM EST - 1 year ago

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Nov 7, 2023, 7:30 AM EST - 1 year ago

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Oct 31, 2023, 7:30 AM EDT - 1 year ago

Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

Oct 10, 2023, 7:30 AM EDT - 1 year ago

Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

Aug 9, 2023, 5:05 PM EDT - 1 year ago

Surmodics to Participate in Upcoming Investor Conferences in August

Aug 6, 2023, 9:00 AM EDT - 1 year ago

Surmodics, Inc. (SRDX) Q3 2023 Earnings Call Transcript

Aug 2, 2023, 7:31 AM EDT - 1 year ago

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Jul 12, 2023, 7:30 AM EDT - 1 year ago

Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

Jun 22, 2023, 4:37 PM EDT - 1 year ago

Surmodics: Regulatory, Fundamental Catalysts Show 90% Upside Potential

Jun 20, 2023, 6:30 AM EDT - 1 year ago

Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

Jun 14, 2023, 7:30 AM EDT - 1 year ago

Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

May 26, 2023, 8:56 AM EDT - 1 year ago

Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)

CHRS ICPT

May 25, 2023, 4:05 PM EDT - 1 year ago

Surmodics to Participate in the Jefferies Healthcare Conference on June 8

Apr 26, 2023, 12:24 PM EDT - 1 year ago

Surmodics, Inc (SRDX) Q2 2023 Earnings Call Transcript

Apr 26, 2023, 7:00 AM EDT - 1 year ago

Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Apr 20, 2023, 7:05 AM EDT - 1 year ago

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

Apr 19, 2023, 7:30 AM EDT - 1 year ago

Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26

Apr 19, 2023, 7:00 AM EDT - 1 year ago

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

Apr 11, 2023, 8:30 AM EDT - 1 year ago

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

Mar 28, 2023, 9:25 AM EDT - 1 year ago

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

Mar 8, 2023, 8:30 AM EST - 2 years ago

Surmodics to Participate in Upcoming Investor Conferences in March

Feb 15, 2023, 10:26 AM EST - 2 years ago

Surmodics Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Feb 6, 2023, 9:41 PM EST - 2 years ago

Surmodics, Inc. (SRDX) Q1 2023 Earnings Call Transcript